Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)
Clinical trial NCT05138523 · COMPLETED
Trial details
- NCT number
- NCT05138523
- Sponsor
- Beker Laboratories
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-21
- Primary completion
- 2020-11-18
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.